• Language: English
    • Italiano Italiano
    • English English

CNCCS

MENU
  • Home
  • Chemical Compounds
    • Compound Collection
    • Our Laboratories
  • Centre for rare diseases
    • Research Areas
    • Rare Diseases
    • Neglected and Poverty Diseases
  • Bioeconomy
    • Edition 2014
    • Edition 2013
    • Edition 2012
    • Edition 2011
  • Media
    • Press Review
    • videos
    • Video Gallery
  • Policies and Certifications
  • Contact Us
    • Job Opportunities

(Italiano) “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people

27 October 2020 Comments (0)  Like

Sorry, this entry is only available in Italian.

 Like (Italiano) “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people

About the Author: info@iwebyou.it

Comments are closed.

Recent Posts

  • (Italiano) Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%»
  • (Italiano) Interview with Matteo Liguori. Research needs time
  • (Italiano) “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people
  • (Italiano) Covid vaccine, IRBM (Pomezia, Rome): «First doses of AstraZeneca vaccine within December, the clinical trials are about to be completed»
  • (Italiano) IRBM Pomezia confirms first vaccine doses may arrive in Dec

Contact Us

Fax: +39.06.91093654
Mail: info@cnccs

CNCCS Scarl
Collection of National Chemical Compounds and Screening Center
Via Pontina km 30,600 – 00040 Pomezia (RM)

News

  • (Italiano) Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%»
  • (Italiano) Interview with Matteo Liguori. Research needs time
  • (Italiano) “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people
  • (Italiano) Covid vaccine, IRBM (Pomezia, Rome): «First doses of AstraZeneca vaccine within December, the clinical trials are about to be completed»

Partners